Credit Suisse’s Fate Therapeutics FATE Stock Holding History

Credit Suisse’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-128,864	Closed	-$273K	–	3078
2023 Q3	$273K	Sell	128,864 -46,813	-27%	-$99.2K	﹤0.01%	2951
2023 Q2	$836K	Buy	175,677 +28,284	+19%	+$135K	﹤0.01%	2495
2023 Q1	$840K	Sell	147,393 -865,912	-85%	-$4.94M	﹤0.01%	2422
2022 Q4	$10.2M	Sell	1,013,305 -2,187	-0.2%	-$22.1K	0.01%	915
2022 Q3	$22.8M	Buy	1,015,492 +10,343	+1%	+$232K	0.03%	610
2022 Q2	$24.9M	Sell	1,005,149 -4,552	-0.5%	-$113K	0.03%	607
2022 Q1	$39.1M	Buy	1,009,701 +11,210	+1%	+$435K	0.03%	534
2021 Q4	$58.4M	Sell	998,491 -16,211	-2%	-$948K	0.03%	402
2021 Q3	$60.1M	Buy	1,014,702 +6,919	+0.7%	+$410K	0.03%	414
2021 Q2	$87.5M	Buy	1,007,783 +1,176	+0.1%	+$102K	0.05%	319
2021 Q1	$83M	Buy	1,006,607 +247,113	+33%	+$20.4M	0.04%	345
2020 Q4	$69.1M	Buy	759,494 +14,289	+2%	+$1.3M	0.03%	394
2020 Q3	$29.8M	Sell	745,205 -56,989	-7%	-$2.28M	0.02%	602
2020 Q2	$27.5M	Buy	802,194 +108,778	+16%	+$3.73M	0.02%	612
2020 Q1	$15.4M	Sell	693,416 -155,985	-18%	-$3.46M	0.01%	761
2019 Q4	$16.6M	Buy	849,401 +3,798	+0.4%	+$74.3K	0.01%	855
2019 Q3	$13.1M	Buy	845,603 +118,238	+16%	+$1.84M	0.01%	876
2019 Q2	$14.8M	Buy	727,365 +661,778	+1,009%	+$13.4M	0.01%	827
2019 Q1	$1.15M	Buy	65,587 +10,608	+19%	+$186K	﹤0.01%	2264
2018 Q4	$705K	Buy	54,979 +30,001	+120%	+$385K	﹤0.01%	2558
2018 Q3	$407K	Sell	24,978 -8,218	-25%	-$134K	﹤0.01%	2934
2018 Q2	$376K	Buy	33,196 +15,354	+86%	+$174K	﹤0.01%	3100
2018 Q1	$174K	Buy	17,842 +6,612	+59%	+$64.5K	﹤0.01%	3300
2017 Q4	$69K	Sell	11,230 -17,237	-61%	-$106K	﹤0.01%	3384
2017 Q3	$112K	Buy	+28,467	New	+$112K	﹤0.01%	3586
2017 Q2	–	Sell	-12,372	Closed	-$56K	–	3441
2017 Q1	$56K	Buy	+12,372	New	+$56K	﹤0.01%	3366